Cargando…

Hepatitis A susceptibility parallels high COVID-19 mortality

BACKGROUND/AIM: COVID-19 has become the biggest health problem of this century. It has been hypothesized that immunity against hepatitis A virus (HAV) may provide protection from COVID- 19. MATERIALS AND METHODS: As of 10June 2020, the infection had spread to 213 countries, with 7.3 million people i...

Descripción completa

Detalles Bibliográficos
Autores principales: SARIALİOĞLU, Faik, BELEN, Fatma Burcu, HAYRAN, Kadir Mutlu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Scientific and Technological Research Council of Turkey 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991879/
https://www.ncbi.nlm.nih.gov/pubmed/32718125
http://dx.doi.org/10.3906/sag-2007-133
_version_ 1783669262262468608
author SARIALİOĞLU, Faik
BELEN, Fatma Burcu
HAYRAN, Kadir Mutlu
author_facet SARIALİOĞLU, Faik
BELEN, Fatma Burcu
HAYRAN, Kadir Mutlu
author_sort SARIALİOĞLU, Faik
collection PubMed
description BACKGROUND/AIM: COVID-19 has become the biggest health problem of this century. It has been hypothesized that immunity against hepatitis A virus (HAV) may provide protection from COVID- 19. MATERIALS AND METHODS: As of 10June 2020, the infection had spread to 213 countries, with 7.3 million people infected and 413,733 dead. This data was combined with the World Health Organization susceptibility classification on the worldwide prevalence of HAV, and the relationship between HAV susceptibility and COVID-19 mortality were analyzed. RESULTS: When the data from 213 countries were analyzed, it was found that there was a significant increasing trend in COVID-19 mortality rates by HAV susceptibility (P <0.001). Using a cut-off of 200/million population, the mortality risk associated with living in a more susceptible country (medium/high) was 27.8 times higher (95% CI for OR: 3.6–213.2) CONCLUSION: The results of this study showed that, despite confounding factors in different countries, hepatitis A susceptibility of the population may have been correlated with COVID-19 mortality. This observation needs to be confirmed by further studies.
format Online
Article
Text
id pubmed-7991879
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Scientific and Technological Research Council of Turkey
record_format MEDLINE/PubMed
spelling pubmed-79918792021-03-30 Hepatitis A susceptibility parallels high COVID-19 mortality SARIALİOĞLU, Faik BELEN, Fatma Burcu HAYRAN, Kadir Mutlu Turk J Med Sci Article BACKGROUND/AIM: COVID-19 has become the biggest health problem of this century. It has been hypothesized that immunity against hepatitis A virus (HAV) may provide protection from COVID- 19. MATERIALS AND METHODS: As of 10June 2020, the infection had spread to 213 countries, with 7.3 million people infected and 413,733 dead. This data was combined with the World Health Organization susceptibility classification on the worldwide prevalence of HAV, and the relationship between HAV susceptibility and COVID-19 mortality were analyzed. RESULTS: When the data from 213 countries were analyzed, it was found that there was a significant increasing trend in COVID-19 mortality rates by HAV susceptibility (P <0.001). Using a cut-off of 200/million population, the mortality risk associated with living in a more susceptible country (medium/high) was 27.8 times higher (95% CI for OR: 3.6–213.2) CONCLUSION: The results of this study showed that, despite confounding factors in different countries, hepatitis A susceptibility of the population may have been correlated with COVID-19 mortality. This observation needs to be confirmed by further studies. The Scientific and Technological Research Council of Turkey 2021-02-26 /pmc/articles/PMC7991879/ /pubmed/32718125 http://dx.doi.org/10.3906/sag-2007-133 Text en Copyright © 2021 The Author(s) This article is distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/4.0/ ), which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Article
SARIALİOĞLU, Faik
BELEN, Fatma Burcu
HAYRAN, Kadir Mutlu
Hepatitis A susceptibility parallels high COVID-19 mortality
title Hepatitis A susceptibility parallels high COVID-19 mortality
title_full Hepatitis A susceptibility parallels high COVID-19 mortality
title_fullStr Hepatitis A susceptibility parallels high COVID-19 mortality
title_full_unstemmed Hepatitis A susceptibility parallels high COVID-19 mortality
title_short Hepatitis A susceptibility parallels high COVID-19 mortality
title_sort hepatitis a susceptibility parallels high covid-19 mortality
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991879/
https://www.ncbi.nlm.nih.gov/pubmed/32718125
http://dx.doi.org/10.3906/sag-2007-133
work_keys_str_mv AT sarialioglufaik hepatitisasusceptibilityparallelshighcovid19mortality
AT belenfatmaburcu hepatitisasusceptibilityparallelshighcovid19mortality
AT hayrankadirmutlu hepatitisasusceptibilityparallelshighcovid19mortality